{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T02:20:16Z","timestamp":1784082016511,"version":"3.55.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T00:00:00Z","timestamp":1490918400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ministry of Education, Culture, Sports, Science and Technology (JP)","award":["23112706"],"award-info":[{"award-number":["23112706"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genet"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s00439-017-1789-4","type":"journal-article","created":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T00:23:33Z","timestamp":1490919813000},"page":"1237-1245","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Modulation of aberrant splicing in human RNA diseases by chemical compounds"],"prefix":"10.1007","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4498-7420","authenticated-orcid":false,"given":"Naoyuki","family":"Kataoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,31]]},"reference":[{"key":"1789_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/nat.2016.0657","volume":"27","author":"A Aartsma-Rus","year":"2017","unstructured":"Aartsma-Rus A, Krieg AM (2017) FDA approves eteplirsen for duchenne muscular dystrophy: the next chapter in the eteplirsen saga. Nucleic Acid Ther 27:1\u20133. doi:\n                        10.1089\/nat.2016.0657","journal-title":"Nucleic Acid Ther"},{"key":"1789_CR2","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1086\/318808","volume":"68","author":"SL Anderson","year":"2001","unstructured":"Anderson SL, Coli R, Daly IW, Kichula EA, Rork MJ, Volpi SA, Ekstein J, Rubin BY (2001) Familial dysautonomia is caused by mutations of the IKAP gene. Am J Hum Genet 68:753\u2013758. doi:\n                        10.1086\/318808","journal-title":"Am J Hum Genet"},{"key":"1789_CR3","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.bbrc.2003.09.019","volume":"310","author":"SL Anderson","year":"2003","unstructured":"Anderson SL, Qiu J, Rubin BY (2003a) EGCG corrects aberrant splicing of IKAP mRNA in cells from patients with familial dysautonomia. Biochem Biophys Res Commun 310:627\u2013633","journal-title":"Biochem Biophys Res Commun"},{"key":"1789_CR4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0006-291X(03)00971-9","volume":"306","author":"SL Anderson","year":"2003","unstructured":"Anderson SL, Qiu J, Rubin BY (2003b) Tocotrienols induce IKBKAP expression: a possible therapy for familial dysautonomia. Biochem Biophys Res Commun 306:303\u2013309","journal-title":"Biochem Biophys Res Commun"},{"key":"1789_CR5","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/hmg\/10.24.2841","volume":"10","author":"C Andreassi","year":"2001","unstructured":"Andreassi C, Jarecki J, Zhou J, Coovert DD, Monani UR, Chen X, Whitney M, Pollok B, Zhang M, Androphy E, Burghes AH (2001) Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients. Hum Mol Genet 10:2841\u20132849","journal-title":"Hum Mol Genet"},{"key":"1789_CR6","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1203\/PDR.0b013e31822e1825","volume":"70","author":"FB Axelrod","year":"2011","unstructured":"Axelrod FB, Liebes L, Gold-Von Simson G, Mendoza S, Mull J, Leyne M, Norcliffe-Kaufmann L, Kaufmann H, Slaugenhaupt SA (2011) Kinetin improves IKBKAP mRNA splicing in patients with familial dysautonomia. Pediatr Res 70:480\u2013483. doi:\n                        10.1203\/PDR.0b013e31822e1825","journal-title":"Pediatr Res"},{"key":"1789_CR7","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1093\/hmg\/ddt126","volume":"22","author":"R Bochner","year":"2013","unstructured":"Bochner R, Ziv Y, Zeevi D, Donyo M, Abraham L, Ashery-Padan R, Ast G (2013) Phosphatidylserine increases IKBKAP levels in a humanized knock-in IKBKAP mouse model. Hum Mol Genet 22:2785\u20132794. doi:\n                        10.1093\/hmg\/ddt126","journal-title":"Hum Mol Genet"},{"key":"1789_CR8","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1124\/jpet.107.123000","volume":"322","author":"T Bordet","year":"2007","unstructured":"Bordet T, Buisson B, Michaud M, Drouot C, Galea P, Delaage P, Akentieva NP, Evers AS, Covey DF, Ostuni MA, Lacapere JJ, Massaad C, Schumacher M, Steidl EM, Maux D, Delaage M, Henderson CE, Pruss RM (2007) Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis. J Pharmacol Exp Ther 322:709\u2013720. doi:\n                        10.1124\/jpet.107.123000","journal-title":"J Pharmacol Exp Ther"},{"key":"1789_CR9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/ng854","volume":"30","author":"L Cartegni","year":"2002","unstructured":"Cartegni L, Krainer AR (2002) Disruption of an SF2\/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet 30:377\u2013384. doi:\n                        10.1038\/ng854","journal-title":"Nat Genet"},{"key":"1789_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nrg775","volume":"3","author":"L Cartegni","year":"2002","unstructured":"Cartegni L, Chew SL, Krainer AR (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 3:285\u2013298. doi:\n                        10.1038\/nrg775","journal-title":"Nat Rev Genet"},{"key":"1789_CR11","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1182\/blood-2013-09-381665","volume":"122","author":"M Cazzola","year":"2013","unstructured":"Cazzola M, Della Porta MG, Malcovati L (2013) The genetic basis of myelodysplasia and its clinical relevance. Blood 122:4021\u20134034. doi:\n                        10.1182\/blood-2013-09-381665","journal-title":"Blood"},{"key":"1789_CR12","doi-asserted-by":"publisher","first-page":"9808","DOI":"10.1073\/pnas.171105098","volume":"98","author":"JG Chang","year":"2001","unstructured":"Chang JG, Hsieh-Li HM, Jong YJ, Wang NM, Tsai CH, Li H (2001) Treatment of spinal muscular atrophy by sodium butyrate. Proc Natl Acad Sci USA 98:9808\u20139813. doi:\n                        10.1073\/pnas.171105098","journal-title":"Proc Natl Acad Sci USA"},{"key":"1789_CR13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1101\/gad.2014311","volume":"25","author":"A Corrionero","year":"2011","unstructured":"Corrionero A, Minana B, Valcarcel J (2011) Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A. Genes Dev 25:445\u2013459. doi:\n                        10.1101\/gad.2014311","journal-title":"Genes Dev"},{"key":"1789_CR14","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1086\/368263","volume":"72","author":"MP Cuajungco","year":"2003","unstructured":"Cuajungco MP, Leyne M, Mull J, Gill SP, Lu W, Zagzag D, Axelrod FB, Maayan C, Gusella JF, Slaugenhaupt SA (2003) Tissue-specific reduction in splicing efficiency of IKBKAP due to the major mutation associated with familial dysautonomia. Am J Hum Genet 72:749\u2013758. doi:\n                        10.1086\/368263","journal-title":"Am J Hum Genet"},{"key":"1789_CR15","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.celrep.2015.09.053","volume":"13","author":"RB Darman","year":"2015","unstructured":"Darman RB, Seiler M, Agrawal AA, Lim KH, Peng S, Aird D, Bailey SL, Bhavsar EB, Chan B, Colla S, Corson L, Feala J, Fekkes P, Ichikawa K, Keaney GF, Lee L, Kumar P, Kunii K, MacKenzie C, Matijevic M, Mizui Y, Myint K, Park ES, Puyang X, Selvaraj A, Thomas MP, Tsai J, Wang JY, Warmuth M, Yang H, Zhu P, Garcia-Manero G, Furman RR, Yu L, Smith PG, Buonamici S (2015) Cancer-associated SF3B1 hotspot mutations induce cryptic 3\u2032 splice site selection through use of a different branch point. Cell Rep 13:1033\u20131045. doi:\n                        10.1016\/j.celrep.2015.09.053","journal-title":"Cell Rep"},{"key":"1789_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/wrna.1140","volume":"4","author":"L Conti De","year":"2013","unstructured":"De Conti L, Baralle M, Buratti E (2013) Exon and intron definition in pre-mRNA splicing. Wiley Interdiscip Rev RNA 4:49\u201360. doi:\n                        10.1002\/wrna.1140","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"1789_CR17","doi-asserted-by":"publisher","first-page":"e1004105","DOI":"10.1371\/journal.pcbi.1004105","volume":"11","author":"C DeBoever","year":"2015","unstructured":"DeBoever C, Ghia EM, Shepard PJ, Rassenti L, Barrett CL, Jepsen K, Jamieson CH, Carson D, Kipps TJ, Frazer KA (2015) Transcriptome sequencing reveals potential mechanism of cryptic 3\u2032 splice site selection in SF3B1-mutated cancers. PLoS Comput Biol 11:e1004105. doi:\n                        10.1371\/journal.pcbi.1004105","journal-title":"PLoS Comput Biol"},{"key":"1789_CR18","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nrc.2016.51","volume":"16","author":"H Dvinge","year":"2016","unstructured":"Dvinge H, Kim E, Abdel-Wahab O, Bradley RK (2016) RNA splicing factors as oncoproteins and tumour suppressors. Nat Rev Cancer 16:413\u2013430. doi:\n                        10.1038\/nrc.2016.51","journal-title":"Nat Rev Cancer"},{"key":"1789_CR19","doi-asserted-by":"publisher","first-page":"6296","DOI":"10.1158\/1078-0432.CCR-13-0485","volume":"19","author":"FA Eskens","year":"2013","unstructured":"Eskens FA, Ramos FJ, Burger H, O\u2019Brien JP, Piera A, de Jonge MJ, Mizui Y, Wiemer EA, Carreras MJ, Baselga J, Tabernero J (2013) Phase I pharmacokinetic and pharmacodynamic study of the first-in-class spliceosome inhibitor E7107 in patients with advanced solid tumors. Clin Cancer Res 19:6296\u20136304. doi:\n                        10.1158\/1078-0432.CCR-13-0485","journal-title":"Clin Cancer Res"},{"key":"1789_CR20","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nrg3460","volume":"14","author":"RJ Fairclough","year":"2013","unstructured":"Fairclough RJ, Wood MJ, Davies KE (2013) Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches. Nat Rev Genet 14:373\u2013378. doi:\n                        10.1038\/nrg3460","journal-title":"Nat Rev Genet"},{"key":"1789_CR21","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1021\/cb100356k","volume":"6","author":"L Fan","year":"2011","unstructured":"Fan L, Lagisetti C, Edwards CC, Webb TR, Potter PM (2011) Sudemycins, novel small molecule analogues of FR901464, induce alternative gene splicing. ACS Chem Biol 6:582\u2013589. doi:\n                        10.1021\/cb100356k","journal-title":"ACS Chem Biol"},{"key":"1789_CR22","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1101\/gad.2009411","volume":"25","author":"EG Folco","year":"2011","unstructured":"Folco EG, Coil KE, Reed R (2011) The anti-tumor drug E7107 reveals an essential role for SF3b in remodeling U2 snRNP to expose the branch point-binding region. Genes Dev 25:440\u2013444. doi:\n                        10.1101\/gad.2009411","journal-title":"Genes Dev"},{"key":"1789_CR23","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nrg3778","volume":"15","author":"XD Fu","year":"2014","unstructured":"Fu XD, Ares M Jr (2014) Context-dependent control of alternative splicing by RNA-binding proteins. Nat Rev Genet 15:689\u2013701. doi:\n                        10.1038\/nrg3778","journal-title":"Nat Rev Genet"},{"key":"1789_CR24","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00439-016-1683-5","volume":"135","author":"T Geuens","year":"2016","unstructured":"Geuens T, Bouhy D, Timmerman V (2016) The hnRNP family: insights into their role in health and disease. Hum Genet 135:851\u2013867. doi:\n                        10.1007\/s00439-016-1683-5","journal-title":"Hum Genet"},{"key":"1789_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1021\/cb100248e","volume":"6","author":"M Hasegawa","year":"2011","unstructured":"Hasegawa M, Miura T, Kuzuya K, Inoue A, Won Ki S, Horinouchi S, Yoshida T, Kunoh T, Koseki K, Mino K, Sasaki R, Yoshida M, Mizukami T (2011) Identification of SAP155 as the target of GEX1A (Herboxidiene), an antitumor natural product. ACS Chem Biol 6:229\u2013233. doi:\n                        10.1021\/cb100248e","journal-title":"ACS Chem Biol"},{"key":"1789_CR26","doi-asserted-by":"publisher","first-page":"5ra12","DOI":"10.1126\/scitranslmed.3000208","volume":"1","author":"ML Hastings","year":"2009","unstructured":"Hastings ML, Berniac J, Liu YH, Abato P, Jodelka FM, Barthel L, Kumar S, Dudley C, Nelson M, Larson K, Edmonds J, Bowser T, Draper M, Higgins P, Krainer AR (2009) Tetracyclines that promote SMN2 exon 7 splicing as therapeutics for spinal muscular atrophy. Sci Transl Med 1:5ra12. doi:\n                        10.1126\/scitranslmed.3000208","journal-title":"Sci Transl Med"},{"key":"1789_CR27","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"EP Hoffman","year":"1987","unstructured":"Hoffman EP, Brown RH Jr, Kunkel LM (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51:919\u2013928","journal-title":"Cell"},{"key":"1789_CR28","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s10637-013-0046-5","volume":"32","author":"DS Hong","year":"2014","unstructured":"Hong DS, Kurzrock R, Naing A, Wheler JJ, Falchook GS, Schiffman JS, Faulkner N, Pilat MJ, O\u2019Brien J, LoRusso P (2014) A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21\u00a0days to patients with solid tumors. Invest New Drugs 32:436\u2013444. doi:\n                        10.1007\/s10637-013-0046-5","journal-title":"Invest New Drugs"},{"key":"1789_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/wrna.1260","volume":"6","author":"JM Howard","year":"2015","unstructured":"Howard JM, Sanford JR (2015) The RNAissance family: SR proteins as multifaceted regulators of gene expression. Wiley Interdiscip Rev RNA 6:93\u2013110. doi:\n                        10.1002\/wrna.1260","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"1789_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/humu.20401","volume":"28","author":"EC Ibrahim","year":"2007","unstructured":"Ibrahim EC, Hims MM, Shomron N, Burge CB, Slaugenhaupt SA, Reed R (2007) Weak definition of IKBKAP exon 20 leads to aberrant splicing in familial dysautonomia. Hum Mutat 28:41\u201353. doi:\n                        10.1002\/humu.20401","journal-title":"Hum Mutat"},{"key":"1789_CR31","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nchembio.2007.18","volume":"3","author":"D Kaida","year":"2007","unstructured":"Kaida D, Motoyoshi H, Tashiro E, Nojima T, Hagiwara M, Ishigami K, Watanabe H, Kitahara T, Yoshida T, Nakajima H, Tani T, Horinouchi S, Yoshida M (2007) Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA. Nat Chem Biol 3:576\u2013583. doi:\n                        10.1038\/nchembio.2007.18","journal-title":"Nat Chem Biol"},{"key":"1789_CR32","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/ng1207","volume":"34","author":"T Kashima","year":"2003","unstructured":"Kashima T, Manley JL (2003) A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nat Genet 34:460\u2013463. doi:\n                        10.1038\/ng1207","journal-title":"Nat Genet"},{"key":"1789_CR33","doi-asserted-by":"publisher","first-page":"164ra160","DOI":"10.1126\/scitranslmed.3005054","volume":"4","author":"GC Kendall","year":"2012","unstructured":"Kendall GC, Mokhonova EI, Moran M, Sejbuk NE, Wang DW, Silva O, Wang RT, Martinez L, Lu QL, Damoiseaux R, Spencer MJ, Nelson SF, Miceli MC (2012) Dantrolene enhances antisense-mediated exon skipping in human and mouse models of Duchenne muscular dystrophy. Sci Transl Med 4:164ra160. doi:\n                        10.1126\/scitranslmed.3005054","journal-title":"Sci Transl Med"},{"key":"1789_CR34","doi-asserted-by":"publisher","first-page":"e15884","DOI":"10.1371\/journal.pone.0015884","volume":"5","author":"H Keren","year":"2010","unstructured":"Keren H, Donyo M, Zeevi D, Maayan C, Pupko T, Ast G (2010) Phosphatidylserine increases IKBKAP levels in familial dysautonomia cells. PLoS ONE 5:e15884. doi:\n                        10.1371\/journal.pone.0015884","journal-title":"PLoS ONE"},{"key":"1789_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.addr.2015.05.008","volume":"87","author":"R Kole","year":"2015","unstructured":"Kole R, Krieg AM (2015) Exon skipping therapy for Duchenne muscular dystrophy. Adv Drug Deliv Rev 87:104\u2013107. doi:\n                        10.1016\/j.addr.2015.05.008","journal-title":"Adv Drug Deliv Rev"},{"key":"1789_CR36","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nchembio.2007.16","volume":"3","author":"Y Kotake","year":"2007","unstructured":"Kotake Y, Sagane K, Owa T, Mimori-Kiyosue Y, Shimizu H, Uesugi M, Ishihama Y, Iwata M, Mizui Y (2007) Splicing factor SF3b as a target of the antitumor natural product pladienolide. Nat Chem Biol 3:570\u2013575. doi:\n                        10.1038\/nchembio.2007.16","journal-title":"Nat Chem Biol"},{"key":"1789_CR37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00210743","volume":"90","author":"M Krawczak","year":"1992","unstructured":"Krawczak M, Reiss J, Cooper DN (1992) The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 90:41\u201354","journal-title":"Hum Genet"},{"key":"1789_CR38","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/nmeth944","volume":"3","author":"H Kuroyanagi","year":"2006","unstructured":"Kuroyanagi H, Kobayashi T, Mitani S, Hagiwara M (2006) Transgenic alternative-splicing reporters reveal tissue-specific expression profiles and regulation mechanisms in vivo. Nat Methods 3:909\u2013915. doi:\n                        10.1038\/nmeth944","journal-title":"Nat Methods"},{"key":"1789_CR39","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/nprot.2010.107","volume":"5","author":"H Kuroyanagi","year":"2010","unstructured":"Kuroyanagi H, Ohno G, Sakane H, Maruoka H, Hagiwara M (2010) Visualization and genetic analysis of alternative splicing regulation in vivo using fluorescence reporters in transgenic Caenorhabditis elegans. Nat Protoc 5:1495\u20131517. doi:\n                        10.1038\/nprot.2010.107","journal-title":"Nat Protoc"},{"key":"1789_CR40","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-biochem-060614-034316","volume":"84","author":"Y Lee","year":"2015","unstructured":"Lee Y, Rio DC (2015) Mechanisms and regulation of alternative pre-mRNA splicing. Annu Rev Biochem 84:291\u2013323. doi:\n                        10.1146\/annurev-biochem-060614-034316","journal-title":"Annu Rev Biochem"},{"key":"1789_CR41","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/nm.4097","volume":"22","author":"SC Lee","year":"2016","unstructured":"Lee SC, Dvinge H, Kim E, Cho H, Micol JB, Chung YR, Durham BH, Yoshimi A, Kim YJ, Thomas M, Lobry C, Chen CW, Pastore A, Taylor J, Wang X, Krivtsov A, Armstrong SA, Palacino J, Buonamici S, Smith PG, Bradley RK, Abdel-Wahab O (2016) Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins. Nat Med 22:672\u2013678. doi:\n                        10.1038\/nm.4097","journal-title":"Nat Med"},{"key":"1789_CR42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L, Benichou B, Cruaud C, Millasseau P, Zeviani M et al (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80:155\u2013165","journal-title":"Cell"},{"key":"1789_CR43","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/S0140-6736(08)60921-6","volume":"371","author":"MR Lunn","year":"2008","unstructured":"Lunn MR, Wang CH (2008) Spinal muscular atrophy. Lancet 371:2120\u20132133. doi:\n                        10.1016\/S0140-6736(08)60921-6","journal-title":"Lancet"},{"key":"1789_CR44","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1101\/gad.1934910","volume":"24","author":"JL Manley","year":"2010","unstructured":"Manley JL, Krainer AR (2010) A rational nomenclature for serine\/arginine-rich protein splicing factors (SR proteins). Genes Dev 24:1073\u20131074. doi:\n                        10.1101\/gad.1934910","journal-title":"Genes Dev"},{"key":"1789_CR45","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.braindev.2015.05.014","volume":"38","author":"M Matsuo","year":"2016","unstructured":"Matsuo M, Takeshima Y, Nishio H (2016) Contributions of Japanese patients to development of antisense therapy for DMD. Brain Dev 38:4\u20139. doi:\n                        10.1016\/j.braindev.2015.05.014","journal-title":"Brain Dev"},{"key":"1789_CR46","doi-asserted-by":"publisher","first-page":"24246","DOI":"10.1074\/jbc.M314298200","volume":"279","author":"M Muraki","year":"2004","unstructured":"Muraki M, Ohkawara B, Hosoya T, Onogi H, Koizumi J, Koizumi T, Sumi K, Yomoda J, Murray MV, Kimura H, Furuichi K, Shibuya H, Krainer AR, Suzuki M, Hagiwara M (2004) Manipulation of alternative splicing by a newly developed inhibitor of Clks. J Biol Chem 279:24246\u201324254. doi:\n                        10.1074\/jbc.M314298200","journal-title":"J Biol Chem"},{"key":"1789_CR47","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nature08909","volume":"463","author":"TW Nilsen","year":"2010","unstructured":"Nilsen TW, Graveley BR (2010) Expansion of the eukaryotic proteome by alternative splicing. Nature 463:457\u2013463. doi:\n                        10.1038\/nature08909","journal-title":"Nature"},{"key":"1789_CR48","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ncomms1306","volume":"2","author":"A Nishida","year":"2011","unstructured":"Nishida A, Kataoka N, Takeshima Y, Yagi M, Awano H, Ota M, Itoh K, Hagiwara M, Matsuo M (2011) Chemical treatment enhances skipping of a mutated exon in the dystrophin gene. Nat Commun 2:308. doi:\n                        10.1038\/ncomms1306","journal-title":"Nat Commun"},{"key":"1789_CR49","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nchembio.1837","volume":"11","author":"J Palacino","year":"2015","unstructured":"Palacino J, Swalley SE, Song C, Cheung AK, Shu L, Zhang X, Van Hoosear M, Shin Y, Chin DN, Keller CG, Beibel M, Renaud NA, Smith TM, Salcius M, Shi X, Hild M, Servais R, Jain M, Deng L, Bullock C, McLellan M, Schuierer S, Murphy L, Blommers MJ, Blaustein C, Berenshteyn F, Lacoste A, Thomas JR, Roma G, Michaud GA, Tseng BS, Porter JA, Myer VE, Tallarico JA, Hamann LG, Curtis D, Fishman MC, Dietrich WF, Dales NA, Sivasankaran R (2015) SMN2 splice modulators enhance U1\u2013pre-mRNA association and rescue SMA mice. Nat Chem Biol 11:511\u2013517. doi:\n                        10.1038\/nchembio.1837","journal-title":"Nat Chem Biol"},{"key":"1789_CR50","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/ng.259","volume":"40","author":"Q Pan","year":"2008","unstructured":"Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 40:1413\u20131415. doi:\n                        10.1038\/ng.259","journal-title":"Nat Genet"},{"key":"1789_CR51","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1124\/jpet.113.212407","volume":"350","author":"F Rigo","year":"2014","unstructured":"Rigo F, Chun SJ, Norris DA, Hung G, Lee S, Matson J, Fey RA, Gaus H, Hua Y, Grundy JS, Krainer AR, Henry SP, Bennett CF (2014) Pharmacology of a central nervous system delivered 2\u2032-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primates. J Pharmacol Exp Ther 350:46\u201355. doi:\n                        10.1124\/jpet.113.212407","journal-title":"J Pharmacol Exp Ther"},{"key":"1789_CR52","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00439-016-1725-z","volume":"135","author":"JN Robinson-Hamm","year":"2016","unstructured":"Robinson-Hamm JN, Gersbach CA (2016) Gene therapies that restore dystrophin expression for the treatment of Duchenne muscular dystrophy. Hum Genet 135:1029\u20131040. doi:\n                        10.1007\/s00439-016-1725-z","journal-title":"Hum Genet"},{"key":"1789_CR53","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0092-8674(78)90306-9","volume":"14","author":"L Sealy","year":"1978","unstructured":"Sealy L, Chalkley R (1978) The effect of sodium butyrate on histone modification. Cell 14:115\u2013121","journal-title":"Cell"},{"key":"1789_CR54","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1016\/j.bbadis.2013.08.005","volume":"1832","author":"J Seo","year":"2013","unstructured":"Seo J, Howell MD, Singh NN, Singh RN (2013) Spinal muscular atrophy: an update on therapeutic progress. Biochim Biophys Acta 1832:2180\u20132190. doi:\n                        10.1016\/j.bbadis.2013.08.005","journal-title":"Biochim Biophys Acta"},{"key":"1789_CR55","doi-asserted-by":"publisher","first-page":"14060","DOI":"10.1038\/ncomms14060","volume":"8","author":"CL Shirai","year":"2017","unstructured":"Shirai CL, White BS, Tripathi M, Tapia R, Ley JN, Ndonwi M, Kim S, Shao J, Carver A, Saez B, Fulton RS, Fronick C, O\u2019Laughlin M, Lagisetti C, Webb TR, Graubert TA, Walter MJ (2017) Mutant U2AF1-expressing cells are sensitive to pharmacological modulation of the spliceosome. Nat Commun 8:14060. doi:\n                        10.1038\/ncomms14060","journal-title":"Nat Commun"},{"key":"1789_CR56","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1128\/MCB.26.4.1333-1346.2006","volume":"26","author":"NK Singh","year":"2006","unstructured":"Singh NK, Singh NN, Androphy EJ, Singh RN (2006) Splicing of a critical exon of human Survival Motor Neuron is regulated by a unique silencer element located in the last intron. Mol Cell Biol 26:1333\u20131346. doi:\n                        10.1128\/MCB.26.4.1333-1346.2006","journal-title":"Mol Cell Biol"},{"key":"1789_CR57","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1086\/318810","volume":"68","author":"SA Slaugenhaupt","year":"2001","unstructured":"Slaugenhaupt SA, Blumenfeld A, Gill SP, Leyne M, Mull J, Cuajungco MP, Liebert CB, Chadwick B, Idelson M, Reznik L, Robbins C, Makalowska I, Brownstein M, Krappmann D, Scheidereit C, Maayan C, Axelrod FB, Gusella JF (2001) Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am J Hum Genet 68:598\u2013605","journal-title":"Am J Hum Genet"},{"key":"1789_CR58","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/hmg\/ddh046","volume":"13","author":"SA Slaugenhaupt","year":"2004","unstructured":"Slaugenhaupt SA, Mull J, Leyne M, Cuajungco MP, Gill SP, Hims MM, Quintero F, Axelrod FB, Gusella JF (2004) Rescue of a human mRNA splicing defect by the plant cytokinin kinetin. Hum Mol Genet 13:429\u2013436. doi:\n                        10.1093\/hmg\/ddh046","journal-title":"Hum Mol Genet"},{"key":"1789_CR59","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1038\/mt.2016.188","volume":"24","author":"CA Stein","year":"2016","unstructured":"Stein CA (2016) Eteplirsen approved for duchenne muscular dystrophy: the FDA faces a difficult choice. Mol Ther 24:1884\u20131885. doi:\n                        10.1038\/mt.2016.188","journal-title":"Mol Ther"},{"key":"1789_CR60","doi-asserted-by":"publisher","first-page":"e10946","DOI":"10.1371\/journal.pone.0010946","volume":"5","author":"A Takeuchi","year":"2010","unstructured":"Takeuchi A, Hosokawa M, Nojima T, Hagiwara M (2010) Splicing reporter mice revealed the evolutionally conserved switching mechanism of tissue-specific alternative exon selection. PLoS ONE 5:e10946. doi:\n                        10.1371\/journal.pone.0010946","journal-title":"PLoS ONE"},{"key":"1789_CR61","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.cell.2009.02.009","volume":"136","author":"MC Wahl","year":"2009","unstructured":"Wahl MC, Will CL, Luhrmann R (2009) The spliceosome: design principles of a dynamic RNP machine. Cell 136:701\u2013718. doi:\n                        10.1016\/j.cell.2009.02.009","journal-title":"Cell"},{"key":"1789_CR62","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nature07509","volume":"456","author":"ET Wang","year":"2008","unstructured":"Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456:470\u2013476. doi:\n                        10.1038\/nature07509","journal-title":"Nature"},{"key":"1789_CR63","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.1093\/emboj\/cdf480","volume":"21","author":"CL Will","year":"2002","unstructured":"Will CL, Urlaub H, Achsel T, Gentzel M, Wilm M, Luhrmann R (2002) Characterization of novel SF3b and 17S U2 snRNP proteins, including a human Prp5p homologue and an SF3b DEAD-box protein. EMBO J 21:4978\u20134988","journal-title":"EMBO J"},{"key":"1789_CR64","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.tig.2010.12.001","volume":"27","author":"JT Witten","year":"2011","unstructured":"Witten JT, Ule J (2011) Understanding splicing regulation through RNA splicing maps. Trends Genet 27:89\u201397. doi:\n                        10.1016\/j.tig.2010.12.001","journal-title":"Trends Genet"},{"key":"1789_CR65","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nature10496","volume":"478","author":"K Yoshida","year":"2011","unstructured":"Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R, Sato Y, Sato-Otsubo A, Kon A, Nagasaki M, Chalkidis G, Suzuki Y, Shiosaka M, Kawahata R, Yamaguchi T, Otsu M, Obara N, Sakata-Yanagimoto M, Ishiyama K, Mori H, Nolte F, Hofmann WK, Miyawaki S, Sugano S, Haferlach C, Koeffler HP, Shih LY, Haferlach T, Chiba S, Nakauchi H, Miyano S, Ogawa S (2011) Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 478:64\u201369. doi:\n                        10.1038\/nature10496","journal-title":"Nature"},{"key":"1789_CR66","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1073\/pnas.1415525112","volume":"112","author":"M Yoshida","year":"2015","unstructured":"Yoshida M, Kataoka N, Miyauchi K, Ohe K, Iida K, Yoshida S, Nojima T, Okuno Y, Onogi H, Usui T, Takeuchi A, Hosoya T, Suzuki T, Hagiwara M (2015) Rectifier of aberrant mRNA splicing recovers tRNA modification in familial dysautonomia. Proc Natl Acad Sci USA 112:2764\u20132769. doi:\n                        10.1073\/pnas.1415525112","journal-title":"Proc Natl Acad Sci USA"},{"key":"1789_CR67","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.clinthera.2013.11.006","volume":"36","author":"C Zanetta","year":"2014","unstructured":"Zanetta C, Nizzardo M, Simone C, Monguzzi E, Bresolin N, Comi GP, Corti S (2014) Molecular therapeutic strategies for spinal muscular atrophies: current and future clinical trials. Clin Ther 36:128\u2013140. doi:\n                        10.1016\/j.clinthera.2013.11.006","journal-title":"Clin Ther"},{"key":"1789_CR68","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S1097-2765(01)00409-9","volume":"8","author":"J Zhu","year":"2001","unstructured":"Zhu J, Mayeda A, Krainer AR (2001) Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins. Mol Cell 8:1351\u20131361","journal-title":"Mol Cell"},{"key":"1789_CR69","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1471-2164-10-47","volume":"10","author":"L Zhu","year":"2009","unstructured":"Zhu L, Zhang Y, Zhang W, Yang S, Chen JQ, Tian D (2009) Patterns of exon-intron architecture variation of genes in eukaryotic genomes. BMC Genomics 10:47. doi:\n                        10.1186\/1471-2164-10-47","journal-title":"BMC Genomics"}],"container-title":["Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00439-017-1789-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-017-1789-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-017-1789-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,16]],"date-time":"2017-09-16T10:57:19Z","timestamp":1505559439000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00439-017-1789-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,31]]},"references-count":69,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["1789"],"URL":"https:\/\/doi.org\/10.1007\/s00439-017-1789-4","relation":{},"ISSN":["0340-6717","1432-1203"],"issn-type":[{"value":"0340-6717","type":"print"},{"value":"1432-1203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,31]]}}}